- Home
- Applications
- vaccine s storage during its develop
Refine by
Vaccine S Storage During Its Develop Product Applications
8 applications found
Enable different strategies for vaccine development to attack rapidly mutating viruses such as influenza, HCV, HIV, or coronaviruses. Use our platform to assist in the creation and optimization of different types of vaccines such as virus-like particles (VLPs), DNA vaccines, RNA ...
ByTeselaGen Biotechnology, Inc. based in Portola Valley, CALIFORNIA (USA)
The medicines and vaccines developed by the pharmaceutical industry play an important role in the health and well-being of millions of people. In order to ensure the purity, quality and effectiveness of the end products, high standards must be maintained in production. Whether product drying or solvent treatment: Our high-performance blowers and compressors are tailor-made for the different requirements and regulations of the pharmaceutical industry and meet the highest ...
ByPiller Blowers & Compressors GmbH based in Moringen, GERMANY
No single preventive health intervention is more cost-effective than immunization. Immune repertoire analysis has taken a predominant role in the development of vaccination strategies against infectious disease and has enabled characterization of the immune response against pathogens at high ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Real-time Viral Titer Assay Capability. Current viral titer assay methods, a crucial component of vaccine & CGT development and production efforts, are generally slow, labor intensive, subjective, and difficult to standardize, often resulting in large errors or failures during critical production ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)
In the face of the coronavirus pandemic, it is time for the nanotechnology community to shine and build on its experience with nanoscale materials and drug delivery to provide knowledge and tools for COVID-19 [prevention, diagnostics,] vaccine and therapeutics development (Nature Nanotechnology volume 15, page 617(2020)) ...
ByPhornano Holding GmbH based in Korneuburg, AUSTRIA
2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. The particles contain no viral genome and are replicative defective and non-pathogenic. The particle capsid surface has repetitive, immunogenic sites, where peptides of interest can be inserted and allows us to generate monovalent or bivalent vaccines as required. Each peptide of interest will be presented 60 times on the capsid surface and both the innate and adaptive immune systems are activated to ...
By2A Pharma ApS based in Aalborg Øst, DENMARK
DNA-based drug development and production are playing an increasingly important role in modern medicine. The application of DNA-based therapy mainly includes DNA-encoded compound library for new drugs research, genetically engineered bacterias drugs, nuelic acid vaccines, recombinant antibodies, small nucleic acid drugs, and gene editing. Firstly, we can quickly promote the development of new drugs through the construction of DNA coding libraries. Secondly, we can realize the mass production of protein drugs, ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)
Vaccine manufacturing has been widely popular ever since Pasteur developed the rabies vaccine in 1885. Since then vaccine manufacturing has continued to be popular due to the defense that vaccines provide against certain viruses. The human immune system is constantly defending itself against a barrage of viruses and we simply lack the capacity to recognize and fight against these ever changing pathogens. Vaccines are designed to help mobilize the host’s immune system to prevent virus infections and break the ...
ByLonza Group Ltd based in Basel, SWITZERLAND